Seller record · Telehealth service

Brello Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S2, prescription gating: Each plan button opens a payment checkout, and every product page states that no intake form is required before paying and that the intake follows checkout. 1 more criterion also fails; see the table below.

At a glance

Brello HealthTelehealth service

6/8criteria passed

Price: Semaglutide $399 per 3-month plan, then $399 every 11 weeks (struck price $599)
Sells: compounded semaglutide, compounded tirzepatide, and 4 more
FDA letters: None on file

Visit Brello Health See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A women's telehealth service selling compounded semaglutide and tirzepatide, NAD+, sermorelin, glutathione and MICC on 3-month plans that renew every 11 weeks. Its product pages take payment before any intake form, and its terms name Southend Pharmacy as the fulfillment pharmacy.

Operating entity Brello LLC The brand sells from 3 storefronts of its own, recorded here as one entry: Brello Health's website, Brello Health's semaglutide storefront, Brello Health's tirzepatidewoo storefront.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Brello Health's semaglutide storefront; Brello Health's terms and condition page
S2	Prescription gating	FAIL	Brello Health's checkout on its semaglutide storefront; Brello Health's tirzepatidewoo storefront; Brello Health's compounded NAD+ product page
S3	Pharmacy identification	PASS	Brello Health's terms and condition page
S4	Compounding disclosure	PASS	Brello Health's semaglutide storefront; Brello Health's contact us page
S5	Analytical documentation	FAIL	Brello Health's FAQ; Brello Health's refund policy
S6	Business address	PASS	Brello Health's privacy notice; Brello Health's terms and condition page
S7	Price disclosure	PASS	Brello Health's semaglutide storefront; Brello Health's tirzepatidewoo storefront; Brello Health's compounded sermorelin product page; Brello Health's compounded NAD+ product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA healthcare provider reviews each health intake, and a kit ships only if that provider approves treatment.Source: Brello Health's semaglutide storefront; Brello Health's terms and condition page.

S2FAILEach plan button opens a payment checkout, and every product page states that no intake form is required before paying and that the intake follows checkout.Source: Brello Health's checkout on its semaglutide storefront; Brello Health's tirzepatidewoo storefront; Brello Health's compounded NAD+ product page.

S3PASSThe terms name AP Max, Inc. d/b/a Southend Pharmacy as the pharmacy whose prescription fulfillment services the platform provides. No city or state is printed beside the name.Source: Brello Health's terms and condition page.

S4PASSCompounded drug products are not FDA-approved, printed in the disclaimer on each product page and repeated on the contact page.Source: Brello Health's semaglutide storefront; Brello Health's contact us page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the FAQ, the terms or the refund policy.Source: Brello Health's FAQ; Brello Health's refund policy.

S6PASSBrello Health at 415 Westheimer RD. #103, Houston, TX 77006, printed as the business address in the privacy notice. The terms name the company Brello LLC (d/b/a Brello Health) and the privacy notice names it Brello Health, LLC.Source: Brello Health's privacy notice; Brello Health's terms and condition page.

S7PASSCompounded semaglutide at $399 for a 3-month plan that renews at $399 every 11 weeks, shown against a struck-through $599. Compounded tirzepatide at $499 for a 3-month plan against a struck-through $749, and sermorelin at $349 against a struck-through $599. NAD+ and glutathione at $239 for a 3-month plan.Source: Brello Health's semaglutide storefront; Brello Health's tirzepatidewoo storefront; Brello Health's compounded sermorelin product page; Brello Health's compounded NAD+ product page.

S8PASSNo FDA warning letter names Brello, Brello LLC or Brello Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, compounded NAD+ injection, compounded sermorelin, compounded glutathione, MICC.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Unpaid link. Brello Health does not pay the site, and nothing is earned when it is used. Funding.

Visit Brello Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.